Isomorphic Labs Lands $5B Series C Led by Sequoia and Greenoaks, 2.4x Its May Round
Summary
Alphabet's Isomorphic Labs closed a $5 billion Series C co-led by Sequoia Capital and Greenoaks, 2.4x its $2.1B May round and about 8x its $600M March 2025 round. Andreessen Horowitz joined as a new investor alongside existing backers Thrive Capital, GV, CapitalG, Temasek, MGX and the UK Sovereign AI Fund. CEO Demis Hassabis said the money accelerates the IsoDDE platform's expansion from small molecules into biologics and pushes the company toward its first clinical trial submissions in 2027.
Originally reported by bloomberg.com
Read the original article →Original headline: Isomorphic Labs Lands $5B Series C Led by Sequoia and Greenoaks, 2.4x Its May Round